My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

(OP:NUMIF)

0.0341 -0.0002 (-0.58%)

Streaming Delayed Price Updated: 3:32 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about NUMIF

< Previous 1 2 3 4 5 6 7 8 9 Next >

EXCLUSIVE: Bienstar Wellness Starts Treating Patients With Psychedelic Therapy In Brazil, Acquires BRC Saude Mental ↗

July 18, 2022

Zinger Brief The acquisition of BRC Saude Mental & Terapias Assistidas Ltda. provides Bienstar access to the Brazilian market, the largest in Latin America, with a population of 215 million. Ketamine...

Via Benzinga

Numinus Wellness Announces Q3 Results ↗

July 15, 2022

Mental healthcare company advancing psychedelic-assisted therapies Numinus Wellness Inc. (OTCQX: NUMIF) recently announced its fiscal quarter results for the three and nine months ended May 31, 2022.

Via Benzinga

Allied, Compass Pathways Among Top Psychedelic Movers Of Today ↗

July 15, 2022

GAINERS: Allied (OTC:ALID) shares closed up 7.05% at $0.52

Via Benzinga

Psychedelic Stock Gainers And Losers From July 14, 2022 ↗

July 14, 2022

GAINERS: Allied (OTC:ALID) shares closed up 7.63% at $0.49

Via Benzinga

Michael Pollan's 'How To Change Your Mind' Now On Netflix, Here Are Reactions From Experts ↗

July 14, 2022

Michael Pollan's 2018 book “How To Change Your Mind: What the science of psychedelics teaches us about consciousness, dying, addiction, depression, and transcendence” is available on Netflix (NASDAQ:...

Via Benzinga

Psychedelic Stock Gainers And Losers From July 13, 2022 ↗

July 13, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 6.16% at $0.61

Via Benzinga

Allied, Compass Pathways Among Top Psychedelic Movers Of Today ↗

July 12, 2022

GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 4.15% at $0.66

Via Benzinga

Psychedelic Stock Gainers And Losers From July 11, 2022 ↗

July 11, 2022

GAINERS: Allied (OTC:ALID) shares closed up 14.67% at $0.54

Via Benzinga

Allied, GH Research Among Top Psychedelic Movers Of Today ↗

July 08, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 9.74% at $12.85

Via Benzinga

Psychedelic Stock Gainers And Losers From July 7, 2022 ↗

July 07, 2022

GAINERS: Allied (OTC:ALID) shares closed up 14.62% at $0.54

Via Benzinga

Psychedelic Stock Gainers And Losers From July 6, 2022 ↗

July 06, 2022

GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 20.50% at $0.89

Via Benzinga

Numinus Wellness, Mind Medicine Among Top Psychedelic Movers Of Today ↗

July 05, 2022

GAINERS: Numinus Wellness (OTC:NUMIF) shares closed up 13.88% at $0.20

Via Benzinga

Psychedelic Stock Gainers And Losers From July 1, 2022 ↗

July 01, 2022

GAINERS: Allied (OTC:ALID) shares closed up 4.17% at $0.50

Via Benzinga

Psychedelic Stock Gainers And Losers From June 30, 2022 ↗

June 30, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.44% at $10.82

Via Benzinga

Seelos Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today ↗

June 29, 2022

GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 6.77% at $0.69

Via Benzinga

GH Research, Numinus Wellness Among Top Psychedelic Movers Of Today ↗

June 28, 2022

GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 3.03% at $0.85

Via Benzinga

Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗

June 27, 2022

GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 3.12% at $0.82

Via Benzinga

Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗

June 24, 2022

GAINERS: Allied (OTC:ALID) shares closed up 29.44% at $0.56

Via Benzinga

Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today ↗

June 23, 2022

GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 6.63% at $0.71

Via Benzinga

Numinus To Provide Psychedelic-Assisted Therapy In This Western State ↗

June 23, 2022

The mental health care company Numinus Wellness Inc.

Via Benzinga

Psychedelic Stock Gainers And Losers From June 22, 2022 ↗

June 22, 2022

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 4.17% at $3.50

Via Benzinga

Numinus Submits New Patent Application To UN Agency For Psilocybe & Novel Fungi Species ↗

June 22, 2022

Numinus Wellness Inc.

Via Benzinga

Revive Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today ↗

June 21, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 7.43% at $0.31

Via Benzinga

Psychedelic Stock Gainers And Losers From June 17, 2022 ↗

June 17, 2022

GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 5.69% at $0.67

Via Benzinga

Michael Pollan's 'How To Change Your Mind' Coming Soon To Netflix: Documentary Based On Psychedelics Best Seller ↗

June 17, 2022

The freshest news traversing many of the major institutions, researchers' and activists’ accounts on Twitter is the recent release of a docu-series based on writer Michael Pollan’s 2018 book “How To...

Via Benzinga

Psychedelic Stock Gainers And Losers From June 16, 2022 ↗

June 16, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.08% at $10.05 LOSERS:

Via Benzinga

Psychedelic Stock Gainers And Losers From June 15, 2022 ↗

June 15, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 9.11% at $0.62

Via Benzinga

Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill ↗

June 15, 2022

Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider.

Via Benzinga

Psychedelic Stock Gainers And Losers From June 14, 2022 ↗

June 14, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 9.90% at $9.44

Via Benzinga

ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today ↗

June 13, 2022

GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 1.06% at $0.81 LOSERS:

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.